We use cookies to ensure that we give you the best experience on our website. If you continue without changing your settings, we'll assume that you are happy to receive all cookies on the medicines.ie website. Find out more

Aspen

3016 Lake Drive, Citywest Business Campus, Dublin 24, Ireland
Telephone: 003531 630 8400
Medical Information Direct Line: 0080000404142 - Freephone
Medical Information e-mail: aspenmedinfo@professionalinformation.co.uk
Patient Information Leaflet last updated on medicines.ie: 21/04/2017
PIL Lanoxin PG Tablets

When a pharmaceutical company changes an SPC or PIL, a new version is published on medicines.ie. For each version, we show the dates it was published on medicines.ie and the reasons for change.

Updated on 21/04/2017 and displayed until Current
Reasons for adding or updating:
  • Change to section 1 - what the product is used for
  • Change to section 2 - what you need to know - contraindications
  • Change to section 2 - what you need to know - warnings and precautions
  • Change to section 2 - use in children and adolescents
  • Change to section 2 - interactions with other medicines, food or drink
  • Change to section 2 - pregnancy, breast feeding and fertility
  • Change to section 2 - driving and using machines
  • Change to section 3 - how to take/use
  • Change to section 4 - possible side effects
  • Change to section 4 - how to report a side effect
  • Change to section 6 - date of revision
Updated on 18/04/2017 and displayed until 21/04/2017
Reasons for adding or updating:
  • Change to section 1 - what the product is used for
  • Change to section 2 - what you need to know - contraindications
  • Change to section 2 - what you need to know - warnings and precautions
  • Change to section 2 - use in children and adolescents
  • Change to section 2 - interactions with other medicines, food or drink
  • Change to section 2 - pregnancy, breast feeding and fertility
  • Change to section 2 - driving and using machines
  • Change to section 3 - use in children/adolescents
  • Change to section 4 - possible side effects
  • Change to section 4 - how to report a side effect
  • Change to section 6 - date of revision
Updated on 08/04/2014 and displayed until 18/04/2017
Reasons for adding or updating:
  • Change to date of revision
  • Change to MA holder contact details
Updated on 19/11/2013 and displayed until 08/04/2014
Reasons for adding or updating:
  • Change to, or new use for medicine
  • Change to warnings or special precautions for use
  • Change to storage instructions
  • Change to side-effects
  • Change to drug interactions
  • Change to information about pregnancy or lactation
  • Change to information about driving or using machinery
  • Change to further information section
  • Change to date of revision
  • Change to improve clarity and readability
  • Addition of information on alternative format leaflets
Updated on 28/01/2013 and displayed until 19/11/2013
Reasons for adding or updating:
  • Change to date of revision
  • Change to appearance of the medicine
Updated on 27/05/2011 and displayed until 28/01/2013
Reasons for adding or updating:
  • Change to marketing authorisation holder
Updated on 12/03/2010 and displayed until 27/05/2011
Reasons for adding or updating:
  • Change to marketing authorisation holder
Updated on 12/03/2007 and displayed until 12/03/2010
Reasons for adding or updating:
  • Improved electronic presentation
Updated on 31/01/2006 and displayed until 12/03/2007
Reasons for adding or updating:
  • Improved electronic presentation
Updated on 01/11/2005 and displayed until 31/01/2006
Reasons for adding or updating:
  • Improved electronic presentation
Updated on 26/05/2005 and displayed until 01/11/2005
Reasons for adding or updating:
  • New PIL for medicines.ie

Document Links

 
  View all medicines
from this company
View Document
Bookmark and Share

Active Ingredients

 
   Digoxin